Income stars such as Neil Woodford and Bill Mott are set for boosts to their portfolios as AstraZeneca jumped over 3% this morning following the approval of a drug the pharma giant pinned $2bn of future sales.
Opportunities in the pharmaceuticals sector continue to be overlooked, with "phenomenal value" on offer, Invesco Perpetual's Neil Woodford has said.
Neil Woodford's Invesco Perpetual income funds have leapt to the top of the performance tables after two years of underperformance as the manager's value calls finally start to pay off.
Neil Woodford is poised to increase the limit on overseas investments in his £940m Edinburgh investment trust to 20%, as the manager continues to find better income opportunities outside of the UK.
Invesco Perpetual managers Paul Causer and Paul Read have trimmed high yield and credit exposure in favour of government bonds, including Spanish government debt, on their £3.2bn Monthly Income Plus fund.
Rising UK equity income stars at M&G and OMAM have challenged Invesco Perpetual's Neil Woodford on his negative view of BP.
Invesco Perpetual's head of investment Neil Woodford warns BP and Shell are not attractive even with higher oil prices.
Neil Woodford, Invesco Perpetual's star income fund manager, says George Osborne's UK growth forecasts are too optimistic and expects growth to remain lower for longer.
Investment Week brings you all the key points from today's conference call with Invesco Perpetual's income guru Neil Woodford...
Neil Woodford, one of the UK's most highly regarded fund managers, is to give his views on the UK economy and stock market as he addresses investors in a conference call later this morning.